LON:SENS - Sensyne Health Stock Price, News, & Analysis

GBX 159
0.00 (0.00 %)
(As of 07/16/2019 04:00 PM ET)
Today's Range
Now: GBX 159
50-Day Range
MA: GBX 138.29
52-Week Range
Now: GBX 159
Volume13,459 shs
Average VolumeN/A
Market Capitalization£204.43 million
P/E Ratio8.74
Dividend YieldN/A
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. Read More…

Industry, Sector and Symbol

Industry Health Information Services
SectorComputer and Technology
Phone44 3300 581845



Sales & Book Value

Annual Sales£100,000.00
Cash FlowGBX 44.80 per share
Book ValueGBX 57.90 per share



Market Cap£204.43 million
Next Earnings DateN/A

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Sensyne Health (LON:SENS) Frequently Asked Questions

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

What price target have analysts set for SENS?

1 brokers have issued 1-year price targets for Sensyne Health's shares. Their predictions range from GBX 262 to GBX 262. On average, they expect Sensyne Health's share price to reach GBX 262 in the next year. This suggests a possible upside of 64.8% from the stock's current price. View Analyst Price Targets for Sensyne Health.

What is the consensus analysts' recommendation for Sensyne Health?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensyne Health.

Has Sensyne Health been receiving favorable news coverage?

Media coverage about SENS stock has trended positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sensyne Health earned a coverage optimism score of 2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Sensyne Health.

Who are some of Sensyne Health's key competitors?

What other stocks do shareholders of Sensyne Health own?

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 159.

How big of a company is Sensyne Health?

Sensyne Health has a market capitalization of £204.43 million and generates £100,000.00 in revenue each year. Sensyne Health employs 70 workers across the globe.View Additional Information About Sensyne Health.

What is Sensyne Health's official website?

The official website for Sensyne Health is http://www.sensynehealth.com/.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.

MarketBeat Community Rating for Sensyne Health (LON SENS)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  39
MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Featured Article: QQQ ETF

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel